Education
About Us
Working with TipRanks
Follow Us
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | $ 0.00 |
| Gross Profit | $ 251.00K | $ 33.49M | $ 4.93M | $ 2.00M | $ 0.00 |
| Operating Income | $ -67.28M | $ -30.67M | $ -59.83M | $ -53.27M | $ -18.27M |
| EBITDA | $ -64.85M | $ -28.41M | $ -58.67M | $ -71.58M | $ -17.52M |
| Net Income | $ -58.49M | $ -27.70M | $ -58.39M | $ -71.83M | $ -17.99M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 185.43M | $ 76.97M | $ 102.53M | $ 160.92M | $ 25.44M |
| Total Assets | $ 209.58M | $ 105.11M | $ 133.05M | $ 169.93M | $ 29.23M |
| Total Debt | $ 14.35M | $ 16.91M | $ 19.45M | $ 1.74M | $ 2.12M |
| Net Debt | $ -25.88M | $ -36.59M | $ -83.08M | $ -159.18M | $ -23.33M |
| Total Liabilities | $ 22.94M | $ 267.13M | $ 273.75M | $ 258.78M | $ 50.80M |
| Stockholders' Equity | $ 186.64M | $ -162.01M | $ -140.70M | $ -88.86M | $ -21.57M |
| Cash Flow | |||||
| Free Cash Flow | $ -55.67M | $ -50.69M | $ -57.13M | $ -17.03M | $ -13.82M |
| Operating Cash Flow | $ -55.03M | $ -47.43M | $ -50.83M | $ -15.30M | $ -13.54M |
| Investing Cash Flow | $ -120.46M | $ -25.98M | $ -6.30M | $ -1.72M | $ -284.00K |
| Financing Cash Flow | $ 162.23M | $ 24.39M | $ -1.26M | $ 152.75M | $ 37.40M |